Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × ralimetinib × Clear all

Phase

Phase 1 2 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

pembrolizumab 348 Cyclophosphamide 336 Carboplatin 272 Gemcitabine 246 Paclitaxel 243 Nivolumab 230 Cisplatin 212 Radiotherapy 191 Bevacizumab 180 Dexamethasone 167 fludarabine 163 Docetaxel 162 Rituximab 155 Capecitabine 146 Lenalidomide 134 Oxaliplatin 132 Fluorouracil 126 Temozolomide 124 Cytarabine 115 Irinotecan 113 Etoposide 109 Cetuximab 109 fludarabine phosphate 106 venetoclax 105 130-nm albumin-bound paclitaxel 97 Injections 96 Doxorubicin 96 Ipilimumab 95 Azacitidine 93 Filgrastim 91

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02364206 2019-08-14

GLYRad

Centre Jean Perrin

Phase 1/2 Completed

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡